InvestorsHub Logo
Followers 408
Posts 43312
Boards Moderated 0
Alias Born 08/24/2005

Re: None

Thursday, 12/12/2019 2:55:06 PM

Thursday, December 12, 2019 2:55:06 PM

Post# of 226
Upon completion of the Proposed Transaction, the members of Folium will exchange their units for common shares of AUSA such that current shareholders of AUSA will hold approximately 11% of the Resulting Issuer shares and current members of Folium will hold approximately 89% of the Resulting Issuer shares, resulting in a reverse takeover of AUSA. In addition, it is contemplated that prior to completion of the Proposed Transaction, AUSA will re-incorporate under the laws of the State of Delaware.

The Proposed Transaction is anticipated to constitute a fundamental change in accordance with the policies of the CSE, and as such, approval of AUSA Shareholders and CSE will be required. AUSA will seek shareholder approval for the Proposed Transaction, the Delaware re-incorporation, a reverse stock split, and certain ancillary matters at a special meeting of AUSA shareholders at a date to be determined. A copy of the merger agreement and the management information circular prepared in connection with this meeting will be available on AUSA's profile on SEDAR at www.sedar.com.


wow, this is a whole new co now, hope the share-price returns to dollar land !

https://foliumbiosciences.com

$AUSAF!